PexigaNAn MSI-78
General Information
DRACP ID DRACP00266
Peptide Name PexigaNAn MSI-78
Sequence GIGKFLKKAKKFGKAFVKILKK
Sequence Length 22
UniProt ID Not available
PubChem CID Not available
Origin Helical peptide with a predominance of one or more amino acids tryptophane-rich
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
U-937 | Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia | Leukemia | 75% Cytotoxicity at 0.5 µg/ml | MTT assay | 6 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C122H209N31O23
Absent amino acids CDEHMNPQRSTWY
Common amino acids K
Mass 285296
Pl 11.7
Basic residues 9
Acidic residues 0
Hydrophobic residues 10
Net charge 9
Boman Index -1085
Hydrophobicity -15.91
Aliphatic Index 93.18
Half Life
Mammalian: 20 hour
Yeast: 30 min
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 21403917
Title Antitumor activity of antimicrobial peptides against U937 histiocytic cell line
Doi Not available
Year 2011
Literature 2
Pubmed ID 8573171
Title A novel antimicrobial peptide from Bufo bufo gargarizans
Year 1996
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available